[目的]整理分析葛琳仪教授(以下简称葛老)治疗消化系统肿瘤术后胃肠功能紊乱的特色经验.[方法]通过随师门诊,整理相关医案,从病因病机、辨证论治、用药特色等方面总结分析葛老治疗消化系统肿瘤术后胃肠功能紊乱的临证经验,并列举验案一则加以说明.[结果]葛老认为本病的病机主要可以归为:“脾胃虚弱,中焦失和”“情志郁结,肝失疏泄”和“内生诸邪,郁滞不解”三方面,治疗上以健脾和中为基础,常用六君子汤加减,再佐以柴胡、木香、枳壳、佛手、苍术、厚朴、当归、丹参等药物疏肝理气、豁痰化瘀.所举验案中患者辨为脾胃虚弱证,葛老拟健脾和中法随证加减,疗效显著.[结论]葛老以健脾和中为基础,辅以疏肝理气、豁痰化瘀等方法治疗消化系统肿瘤术后胃肠功能紊乱疗效显著,颇具特色,具有重要临床意义.
[Objective] Summarizing Professor FAN Yongsheng's experience in treating children's erythema multiforme.[Method] Collecting medical record from outpatient clinics, to analyze and summarize Professor FAN Yongsheng's understanding of children's erythema multiforme and experience of children's erythema multiforme syndrome differentiation and treatment. [Result] Professor FAN Yongsheng considers the disease is caused by children's spleen qi deficiency and suffering external-contraction at the same time. The characteristics of pathogenesis are "deficiency" "heat" and "static blood" by generalizing. According to the degree of suffering pathogenic qi, the disease can be divided into three stages including spathogenic qi, s incursion in exterior, exuberant blood heat and damage to qi-yin. The treatment can respectively base on dispersing exterior pathogenic qi and cleaning interior heat, or base on cooling blood and eliminating toxins, dispersing blood stasis and removing ecchymosis, or base on reinforcing spleen and stomach, clearing qi aspect and nourishing yin. Professor FAN through the pediatric physiological characteristics and erythema multiforme disease associated with the combination of the idea of treating patients, has achieved satisfactory clinical efficacy.[Conclusion] Professor FAN Yongsheng's treatment experience of children's erythema multiforme has satisfactory clinical efficacy and is worth to use for reference and promotion.
痛风属中医“痹症”范畴,病程迁延、反复发作,随着经济的发展及生活方式的不断变化,痛风的患病率明显上升,且单纯采用药物内服尚无法根治.笔者查阅了大量文献,通过整理发现大量文献表明中药外治、针灸治疗、推拿治疗、中医食疗对痛风具有辅助治疗作用,并取得了良好的临床效果.
目的:系统评价扶正中药联合化疗对Ⅲ-Ⅳ期结直肠癌患者生存期的影响.方法:计算机检索中国生物医学文献数据库、CNKI、VIP、万方数据库,收集扶正中药联合化疗与单用化疗比较对Ⅲ-Ⅳ期结直肠癌患者生存期影响的随机对照试验.对资料进行质量评价,用RevMan 5.2进行Meta分析.结果:共检索到符合纳入标准的中文文献10篇867例患者.文献质量Jadad评分结果显示4篇文献为3分,6篇文献为2分.Meta分析:一年生存率OR3.10,95％ [2.10,4.57],P＜0.0001;两年生存率OR 2.38,95％[1.53,3.70],P=0.0001;三年生存率OR2.32,95％[1.35,3.98],P=0.002;差异具有统计学意义.四年、五年生存率差异无统计学意义.结论:扶正中药联合化疗在延长结直肠癌患者生存期与单纯化疗相比有一定的优势.受纳入文献的方法学质量和样本量限制,上述结论尚待开展更多大样本、高质量研究予以证实.
